블로그

기타 건강 상태

Nitisinone (Orfadin and Nityr)

Patient taking nitisinone

Nitisinone is a synthetic inhibitor used to treat a rare and lifelong genetic disorder called hereditary tyrosinemia type 1 (HT-1). Patients with tyrosinemia type 1 are usually unable to properly break down tyrosine (an amino acid) due to a deficiency of a specific enzyme. The failure of tyrosine breakdown leads to the buildup of tyrosine and its toxic metabolites in the tissues or other body organs. The accumulation of these toxic components causes severe and progressive organ damage, in particular, liver and kidney cancer in HT-1 patients. 

Ask a Specialist About Copay Assistance

(877) 778-0318

Nitisinone slows down the progression of HT-1 by preventing the formation and accumulation of toxic metabolites in the liver and kidney. 

Nitisinone is sold under the brand names Orfadin and Nityr and can only be obtained through a doctor’s prescription.

How Does Nitisinone Treat Hereditary Tyrosinemia Type-1 (HT-1)?

3D illustration of amino acid

Typically, our body breaks down protein into smaller components called amino acids. These amino acids are further broken down in a series of steps via various enzymes. Fumarylacetoacetate hydrolase (FAH) is an enzyme needed for the final breakdown of tyrosine and releases substances that the body utilizes to perform different functions. 

People who are born with HT-1 lack the FAH enzyme. Their bodies only metabolize a small amount of tyrosine and produce large amounts of toxic metabolites. Nitisinone works to stop the tyrosine breakdown pathway by working as an inhibitor (a component that stops the enzyme activity).

Mode of Action

Nitisinone acts as an inhibitor of hydroxyphenylpyruvate dioxygenase (HPPD), an enzyme involved in the third step of the tyrosine breakdown pathway. Nitisinone blocks the action of this third enzyme, so the reaction won’t proceed further and make toxic metabolites in HT-1 patients. 

How Is Nitisinone Used?

To get effective results, nitisinone must be used in combination with a diet that is low in protein and has a low level of tyrosine and phenylalanine. Phenylalanine is converted in the body into tyrosine; therefore, reducing foods rich in phenylalanine is recommended for HT-1 patients. Phenylalanine is found in most protein-rich foods such as milk, cheese, eggs, nuts, soybeans, beef, chicken, pork, beans, and fish.

Since nitisinone and HT-1 cause too much tyrosine in the blood, taking a diet rich in tyrosine may lead to brain, skin, and eye problems. 

Dosage Forms and Strengths

Nitisinone comes in tablet, oral suspension, and capsule forms. Each form is administered orally and is available with different nitisinone strengths:

  • 정제 are available in 2 mg, 5 mg, and 10 mg doses.
  • Oral suspension is a white, slightly viscous, and opaque suspension that contains 4 mg nitisinone/ml (each 1 ml contains 4 mg of nitisinone).
  • Hard capsules contain white to off-white powder of 2 mg, 5 mg, 10 mg, and 20 mg nitisinone. 

전문가와 상담하세요

상담 일정을 잡으세요

복용 정보

The dose of nitisinone can vary from patient to patient and is determined by their body weight and their health status. The recommended starting dose for adult and pediatric patients is 0.5 mg/kg twice a day for 4 weeks (1 month). 

Dose Adjustment

The dose of nitisinone is adjusted according to the level of succinylacetone (toxic metabolite) in the serum or urine of the HT-1 patient. For instance:

  • If succinylacetone is still detectable in the serum of HT-1 patients after taking a stable dose (0.5 mg) for four weeks, then the dose is increased from 0.5 to 0.75 mg/kg twice daily.
  • Once the succinylacetone is undetectable in the serum of HT-1 patients, the dose is adjusted according to the patient’s body weight. The maximum dose of nitisinone capsules and oral suspension is usually not more than 1 or 2 mg/kg body weight and is taken once a day. 

It is recommended to consult your healthcare provider if your condition deteriorates after switching dosing from twice a day to once a day. 

복용량 누락

If you missed your nitisinone dose, take it immediately. If it is almost time for your next dose, skip the missed dose and take only the next dose. Do not take a double dose. 

Method of Administration

Nitisinone tablets, capsules, and oral suspension are all taken orally (by mouth) as directed by your doctor. 

How Should I Take the Nitisinone Capsule?

You should take nitisinone capsules on an empty stomach either 1 hour before a meal or 2 hours after a meal. 

If you have difficulty swallowing the whole capsule, you can open the capsule and mix the contents in a spoonful of water, applesauce, or baby formula. The mixture should be swallowed as is without chewing it. 

How Should I Take Nitisinone Oral Suspension?

You will get nitisinone oral suspension (liquid) in a bottle along with an oral syringe to withdraw the correct volume of medication from the bottle. 

If you are taking your first dose, let your suspension bottle warm to room temperature for 30 to 60 minutes and shake it vigorously for 20 seconds so that the nitisinone disperses well. 

You can take the nitisinone oral suspension with or without food. 

How Should I Take Nitisinone Tablets?

You can take nitisinone tablets with or without food. If you have difficulty swallowing the whole tablet, you can crush the tablet and mix it in a spoonful of water, applesauce, or baby formula. The mixture should be swallowed immediately without chewing. 

공제금 지원 받기

재정 지원
(877) 778-0318

부작용

Nitisinone may cause unwanted side effects. Some side effects are common and usually go away during treatment. In other cases, however, side effects could be severe and potentially life-threatening. 

The following are some of the side effects you may experience after taking nitisinone suspension, tablets, or capsules:

  • Headache, diarrhea, or upset stomach due to glycerol content of nitisinone oral suspension
  • A severe allergic reaction with symptoms such as hives; rash; and swelling of lips, tongue, and throat
  • Hair thinning
  • Vision changes, and eyes becoming sensitive to light (photophobia)
  • Eye redness, irritation, and pain 
  • 코피

In more severe cases, when you don’t eat diets restricted in tyrosine and phenylalanine, you may experience some adverse side effects due to elevated levels of tyrosine, which has been associated with toxicity to the eyes, skin, and the nervous system. Adverse symptoms include:

  • 건성 피부
  • Keratitis (corneal ulcers)
  • Corneal opacities
  • Cataracts
  • Conjunctivitis (pink eye)
  • Painful patch of thick skin (hyperkeratotic plaques) on the palms or soles
  • Leukopenia and severe 혈소판 감소증 

Precautions before Taking Nitisinone

While on nitisinone treatment, you should consume a diet that restricts tyrosine and phenylalanine intake.

You SHOULD NOT take nitisinone if you:

  • Are pregnant or intend to conceive.
  • Are breastfeeding or planning to breastfeed.
  • Are allergic to nitisinone or any of its components.
  • Have a previous history of eye problems (such as cataracts or corneal ulcers).

비용

The cost of nitisinone capsules, tablets, and oral suspension varies depending on the pharmacy you visit. The following are the costs of nitisinone capsules and suspension with different strengths. 

Cost of Nitisinone capsules

  • Nitisinone 2 mg capsule costs about $5,748 ($95.80 per capsule) for a supply of 60 capsules.
  • Nitisinone 5 mg capsule costs about $14,354.93 ($239.25 per capsule) for a supply of 60 capsules.
  • Nitisinone 10 mg capsule costs about $28,700.39 ($478.34 per capsule) for a supply of 60 capsules.
  • Nitisinone 20 mg capsule costs about $57,391.27 ($956.52 per capsule) for a supply of 60 capsules.

Cost of Nitisinone Oral suspension (4 mg/ml)

Nitisinone oral suspension costs about $18,772.78 for a supply of 90 ml.

The cost of nitisinone tablets is not publicly available. 

참고문헌:

  1. King, L. S., Trahms, C., & Scott, C. R. (2017). Tyrosinemia type I. GeneReviews®[Internet].
  2. McKiernan, P. J. (2013). Nitisinone for the treatment of hereditary tyrosinemia type I. Expert Opinion on Orphan Drugs, 1(6), 491-497.
  3. European Medicine Agency. Nitisinone prescribing information https://www.ema.europa.eu/en/documents/product-information/orfadin-epar-product-information_en.pdf
  4. US. Food and Drug Administration. Nitisinone prescribing information https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21232lbl.pdf
이 정보는 의학적 조언이나 치료를 대체할 수 없습니다. 새로운 치료를 시작하기 전에 담당 의사 또는 의료 서비스 제공자와 건강 상태에 대해 상담하십시오. AmeriPharma® Specialty Care는 제공된 정보 또는 그 결과로 내려진 진단이나 치료에 대해 어떠한 책임도 지지 않으며, 콘텐츠의 신뢰성에 대해서도 책임을 지지 않습니다. AmeriPharma® Specialty Care는 여기에 나열된 모든 웹사이트/기관을 운영하는 것은 아니며, 해당 콘텐츠의 가용성이나 신뢰성에 대해서도 책임을 지지 않습니다. 이러한 목록은 AmeriPharma® Specialty Care의 보증, 후원 또는 추천을 암시하거나 구성하지 않습니다. 이 웹페이지에는 AmeriPharma® Specialty Care와 제휴하지 않은 제약 회사의 상표 또는 등록 상표인 브랜드 처방약에 대한 참조가 포함될 수 있습니다.
Dr. Abdelaziz Alsamarah
의학적으로 검토됨 Abdelaziz Alsamarah 박사, PharmD, MSPS, BCSCP

알사마라 박사는 2011년 요르단 대학교에서 약학박사 학위를 받았습니다. 고등 교육을 위해 2014년 캘리포니아주 포모나에 있는 웨스턴 의과대학에 입학하여 컴퓨터 지원 약물 설계(CADD) 전공으로 약학 석사 학위를 받았습니다. 그는 주요 과학 저널에 여러 논문을 집필 및 공저했습니다. 졸업 후 알사마라 박사는 다양한 약국에서 근무하다가 정맥 주사 환자 관리에 대한 열정을 갖게 되었습니다. 그의 전문 분야는 감염성 질환, 영양 지원, 단일클론 항체입니다. 여가 시간에는 세 자녀와 함께 권투, 자전거 타기, 그림 그리기를 즐깁니다.

문의하기

아래 HIPAA 규격 양식을 사용하여 처방전 재조제를 요청하세요. 복용 중인 약이나 복용 방법에 대한 문의 사항이 있으시면 문의하기 페이지를 방문하시거나 다음 번호로 전화해 주세요. (877) 778-0318.

HIPAA Compliant

제출하면 AmeriPharma에 동의하는 것입니다. 이용 약관, 개인정보 보호정책, 그리고 개인정보 보호 관행 고지

ko_KRKorean